Trial intelligence / Profile preview

Oral potassium supplementation and hormonal/autonomic regulation in healthy men

2013-004460-66Phase 4Completed

Sponsor
Jørgen Jeppesen
Start
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of potassium chloride in Abnormality of blood pressure regulation and hypertension (HTN), sponsored by Jørgen Jeppesen. Primary endpoint: Angiotensin II stimulated S-aldosterone. Started Mar 2014; status: completed.

02

Drugs

potassium chloride
03

Conditions

Abnormality of blood pressure regulationhypertension (HTN)

Beyond the preview

Go deeper on 2013-004460-66.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-004460-66.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call